SPARC and malignant colon neoplasm: Consistently, Sparc reduction by dysregulated methylation in the promoter region has been reported in other chronic diseases such as age-dependent disc degeneration (Tajerian et al, 2011), Sjogren’s syndrome (Feldt et al, 2022), and colon cancer (Cheetham et al, 2008).